您现在的位置是：首页>权威专家> 宫颈癌

Shelly Seward M.D.

Shelly Seward M.D.

所在科室：妇科

就职医院：Karmanos cancer center

医生擅长：

在线咨询医学顾问 电话热线：400-666-7998

医生介绍

 ·         Gender

·         Female

·         Multidisciplinary Team(s)

·         Gynecologic Oncology 

·         Department/Research Program(s)

·         GYN Oncology 

·         Cancer Type(s)

·         Cervical cancer 
Ovarian cancer 
Uterine cancer 
Vulvar Cancer 

·         Contact Info

·         Email:
sseward@med.wayne.edu

 

来自 <http://www.karmanos.org/physicians/Shelly-Seward?Disease=191&PageIndex=0&SortDirection=1>

 

·         Education

·         Fellowship
Gynecologic Oncology, Wayne State Unviersity, Detroit, MI
Residency
Obstetrics and Gynecology, The Ohio State University, Columbus, OH

·         Professional Memberships/Associations

·         American College of Obstetrics and Gynecology 
Society of Gynecologic Oncology 
American Society of Clinical Oncology 

·         Board Certifications

·         American Board of Obstetrics and Gynecology

·         Clinical Interests

·         Gynecologic Oncology 

·         Awards

·         2009 Fromm Research Award - 2nd Place
2008 Resident Research Award - 1st Place

·         Publications

·         Authors: Seward S, Ali-Fehmi R, Munkarah AR, Semaan A, Al-Wahab ZR, Elshaikh MA, Cote ML, Morris RT, Bandyopadhyay S. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system. Int J Gynecol Cancer. 2012 Mar;22(3):452-6.
Authors: Vay A, Kumar S, Seward S, Semaan A, Schiffer CA, Munkarah AR, Morris RT. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis. Gynecol Oncol. 2011 Dec;123(3):456-60. Epub 2011 Aug 19.
Authors: Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹). Pharm Res. 2011 Dec;28(12):3079-90. Epub 2011 Aug 5.
Authors: Mahdi H, Kumar S, Seward S, Semaan A, Batchu R, Lockhart D, Tamimi H, Munkarah AR. Prognostic impact of laterality in malignant ovarian germ cell tumors. Int J Gynecol Cancer. 2011 Feb;21(2):257-62.
Authors: Mahdi H, Thrall M, Kumar S, Hanna R, Seward S, Lockhart D, Morris RT, Swensen R, Munkarah AR. The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients. J Surg Oncol. 2011 Jun 1;103(7):724-9. doi: 10.1002/jso.21869. Epub 2011 Jan 16.

 

相关报道资讯

在线预约

绿色快速预约通道

Shelly Seward M.D.

请正确填写预约人和联系人等信息，提交需求成功后，请保持联系电话畅通，客服会在48小时内与您联系确认信息。客服热线：400-666-7998

资讯 查看

愈见大"CAR"|王兴兵教授团队:破局复发骨髓瘤患者治疗困境,创新药物带来治疗新选择! 4.17 全国肿瘤防治宣传周第三弹!2024抗癌新势力--TIL疗法带来生存突破 4.15 全国肿瘤防治宣传周第一弹!告诉14亿中国人如何科学防癌 2024 癌"愈"新生|第30届全国肿瘤防治宣传周大型科普云讲堂不容错过​! 15：00 愈见大"CAR"|陈丽娟教授团队:破局复发骨髓瘤患者治疗困境,创新药物带来治疗新选择! FDA批准|全癌种可用的神奇抗癌药-DS-8201,横扫数十款HER2阳性癌种,打破使用限制 "肺"常守护,"肺"常健康--2024肺癌公益科普医患交流会圆满结束 愈见大"CAR"|复发/难治骨髓瘤再添新疗法!CAR-T细胞疗法如何治疗骨髓瘤 ?

推荐专家

医院 全部医院

Shelly Seward M.D.

Karmanos cancer center 妇科

擅长

简介

 ·         Gender

·         Female

·         Multidisciplinary Team(s)

·         Gynecologic Oncology 

·         Department/Research Program(s)

·         GYN Oncology 

·         Cancer Type(s)

·         Cervical cancer 
Ovarian cancer 
Uterine cancer 
Vulvar Cancer 

·         Contact Info

·         Email:
sseward@med.wayne.edu

 

来自 <http://www.karmanos.org/physicians/Shelly-Seward?Disease=191&PageIndex=0&SortDirection=1>

 

·         Education

·         Fellowship
Gynecologic Oncology, Wayne State Unviersity, Detroit, MI
Residency
Obstetrics and Gynecology, The Ohio State University, Columbus, OH

·         Professional Memberships/Associations

·         American College of Obstetrics and Gynecology 
Society of Gynecologic Oncology 
American Society of Clinical Oncology 

·         Board Certifications

·         American Board of Obstetrics and Gynecology

·         Clinical Interests

·         Gynecologic Oncology 

·         Awards

·         2009 Fromm Research Award - 2nd Place
2008 Resident Research Award - 1st Place

·         Publications

·         Authors: Seward S, Ali-Fehmi R, Munkarah AR, Semaan A, Al-Wahab ZR, Elshaikh MA, Cote ML, Morris RT, Bandyopadhyay S. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system. Int J Gynecol Cancer. 2012 Mar;22(3):452-6.
Authors: Vay A, Kumar S, Seward S, Semaan A, Schiffer CA, Munkarah AR, Morris RT. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis. Gynecol Oncol. 2011 Dec;123(3):456-60. Epub 2011 Aug 19.
Authors: Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹). Pharm Res. 2011 Dec;28(12):3079-90. Epub 2011 Aug 5.
Authors: Mahdi H, Kumar S, Seward S, Semaan A, Batchu R, Lockhart D, Tamimi H, Munkarah AR. Prognostic impact of laterality in malignant ovarian germ cell tumors. Int J Gynecol Cancer. 2011 Feb;21(2):257-62.
Authors: Mahdi H, Thrall M, Kumar S, Hanna R, Seward S, Lockhart D, Morris RT, Swensen R, Munkarah AR. The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients. J Surg Oncol. 2011 Jun 1;103(7):724-9. doi: 10.1002/jso.21869. Epub 2011 Jan 16.

 

TA的文章视频

  • 在线咨询
  • 病友群
  • 联系电话
    咨询电话400-6667998
  • 返回顶部